Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.

Catalysis and sulfa drug resistance in dihydropteroate synthase.

Yun MK, Wu Y, Li Z, Zhao Y, Waddell MB, Ferreira AM, Lee RE, Bashford D, White SW.

Science. 2012 Mar 2;335(6072):1110-4. doi: 10.1126/science.1214641.

2.

Dihydropteroate synthase gene mutations in Pneumocystis and sulfa resistance.

Huang L, Crothers K, Atzori C, Benfield T, Miller R, Rabodonirina M, Helweg-Larsen J.

Emerg Infect Dis. 2004 Oct;10(10):1721-8. Review.

3.

[Diaminodiphenylsulfone resistance of Mycobacterium leprae due to mutations in the dihydropteroate synthase gene].

Kai M.

Nihon Hansenbyo Gakkai Zasshi. 2004 Sep;73(3):221-6. Review. Japanese.

PMID:
15508724
4.

Sulfa and trimethoprim-like drugs - antimetabolites acting as carbonic anhydrase, dihydropteroate synthase and dihydrofolate reductase inhibitors.

Capasso C, Supuran CT.

J Enzyme Inhib Med Chem. 2014 Jun;29(3):379-87. doi: 10.3109/14756366.2013.787422. Review.

PMID:
23627736
5.
6.

Sulfa use, dihydropteroate synthase mutations, and Pneumocystis jirovecii pneumonia.

Stein CR, Poole C, Kazanjian P, Meshnick SR.

Emerg Infect Dis. 2004 Oct;10(10):1760-5. Review.

7.

Utility of the Biosynthetic Folate Pathway for Targets in Antimicrobial Discovery.

Bourne CR.

Antibiotics (Basel). 2014 Jan 21;3(1):1-28. doi: 10.3390/antibiotics3010001. Review.

Supplemental Content

Support Center